Skip to main content

Arctic Canadian Diamond Company Ltd. files for CCAA protection

CALGARY, Alberta, May 01, 2026 (GLOBE NEWSWIRE) — Burgundy Diamond Mines Limited (ASX:BDM) (Burgundy or the Company) advises that its subsidiary, Arctic Canadian Diamond Company Ltd. (“ACDC”) has filed for insolvency protection under the Companies’ Creditors Arrangement Act (“CCAA”). Incorporated in British Columbia, ACDC has obtained an order from the Supreme Court of British Colombia (the “Court”), granting ACDC protection under the CCAA. ACDC owns and operates the Ekati Diamond Mine. The protection order also extends to Burgundy by way of a non-applicant stay party order. Burgundy intends to use the CCAA process to engage in discussions with its lenders, creditors and other stakeholders, to solicit and evaluate strategic alternatives to restructure ACDC financially and operationally, as it continues to...

Continue reading

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of April 30, 2026

HOUSTON, May 01, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of April 30, 2026. As of April 30, 2026, the Company’s net assets were $2.8 billion, and its net asset value per share was $16.62. As of April 30, 2026, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 676% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 520%.STATEMENT OF ASSETS AND LIABILITIESAPRIL 30, 2026   // (UNAUDITED)     (in millions)Investments   $ 3,921.0  Cash and...

Continue reading

Future Mineral Announces Management and Board Changes; Engages Native Ads for Investor Relations

TORONTO, May 01, 2026 (GLOBE NEWSWIRE) — Future Mineral Resources Inc. (“Future Mineral” or the “Company”) (TSX: FMR) is pleased to announce that Indivar Pathak has been appointed as the president and chief executive officer of the Company, effective immediately. In addition, Con Steers has been appointed as the non-executive chairman, Stephen Woodhead has been appointed as the chief financial officer, and Dr. Andreas Rompel has been appointed as the chief operating officer, all also effective immediately. Indivar Pathak A graduate of Delhi University with a Bachelor of Commerce degree, Mr. Pathak is a finance professional holding professional certifications as a Certified Public Accountant (CPA) and Certified Management Accountant (CMA) since 2002. Mr. Pathak’s professional odyssey commenced at Deutsche Bank, where he honed his...

Continue reading

SalesCloser Secures U.S. Patent for AI-Powered Conversational Workflow Technology

Patent Grant Validates Core Innovation and Strengthens Competitive Moat in Rapidly Growing AI Sales Automation Market Vancouver, BC, May 01, 2026 (GLOBE NEWSWIRE) — SalesCloser Technologies Ltd. (“SalesCloser” or the “Company”) (TSXV: SCAI) (FSE: MJ5), a pioneer in autonomous AI sales technology, today announced that the United States Patent and Trademark Office (the “USPTO”) has granted the Company U.S. Patent No. US12526253B1 for its “System and Method for Graph-Based Conversational-Flow Editing” technology. The patent, which protects the Company’s foundational approach to democratizing AI agent creation, represents formal recognition of SalesCloser’s unique innovation in making sophisticated conversational AI accessible to non-technical business users. The granted patent covers technology that is already...

Continue reading

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

VANCOUVER, British Columbia, May 01, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the appointment of Dr. Jeymi Tambiah as Chief Medical Officer (CMO) as well as the retirement of Dr. Mark Kowalski, Eupraxia’s current CMO. Dr. Jeymi Tambiah (MB ChB, FRCS, MS, FAPCR, FFPM), is a Board Certified Cardiothoracic Surgeon physician scientist who practiced at Guys and St Thomas’ Hospitals prior to entering the biopharmaceutical industry in 2008. Dr. Tambiah brings over 18 years of experience in clinical development, medical and regulatory strategy,...

Continue reading

Petrus Resources Declares Monthly Dividend for May 2026

CALGARY, Alberta, May 01, 2026 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable May 29, 2026, to shareholders of record on May 15, 2026. The dividend is designated as an eligible dividend for Canadian income tax purposes. Dividend Reinvestment Plan (“DRIP”)Petrus’ DRIP enables eligible shareholders to reinvest all or part of their cash dividends into additional common shares of the Company. Participation in the DRIP is optional. Eligible shareholders who elect to reinvest their cash dividends under the DRIP will receive common shares issued from treasury at a discount of 3% from the market price of the common shares. To participate in the DRIP, registered shareholders...

Continue reading

Trident Resources Engages Marketing Groups and Announces the Recent Exercise of 1.38M Warrants for $1.87M in Cash

Vancouver, BC, May 01, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce it has engaged with several marketing groups as part of its corporate strategy to increase investors awareness. Additionally, the Company announces the recent exercise of just over 1.38 million warrants bringing in cash proceeds of CAD $1.87 million. Connect 4 Marketing Ltd.: The Company has entered into an agreement dated May 1, 2026 (the “Connect 4 Agreement”) with Connect 4 Marketing Ltd. (“Connect 4“) of Brossard, Quebec whereby Connect 4 will provide marketing and media distribution for an initial term of three (3) months commencing on May 1, 2026. An upfront fee of CAD$150,000 is payable. Connect 4 will provide the Company with digital marketing and similar services,...

Continue reading

HII’s Ingalls Shipbuilding Hosts “Signing Day” Celebrating Shipbuilder Academy Graduates

PASCAGOULA, Miss., May 01, 2026 (GLOBE NEWSWIRE) — HII’s (NYSE: HII) Ingalls Shipbuilding division hosted its annual “Signing Day” today, recognizing 49 high school seniors from across the Gulf Coast who have completed the Ingalls Shipbuilder Academy (ISA) and accepted contingent employment offers with the company. Modeled after traditional athletic signings, the ceremony celebrates students as they formally commit to launching their careers in shipbuilding. “Through the Ingalls Shipbuilder Academy, we are developing the next generation of skilled shipbuilders,” said Brian Blanchette, Ingalls Shipbuilding president. “Today we celebrate their first step toward meaningful, rewarding careers being part of something much bigger than themselves. By choosing technical training while still in high school, these students have shown the...

Continue reading

PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada

Acquisition of prescription files, patient records, and related operational data at an aggregate purchase price of $300,000 The acquired assets will be transferred to PharmaCorp’s existing PharmaChoice bannered pharmacy in Western CanadaSASKATOON, Saskatchewan, May 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform for pharmacist-led community pharmacy ownership, is pleased to announce the completion of its acquisition from an arm’s length vendor (the “Vendor”) of the prescription files, patient records and related operational data (collectively, the “Pharmacy Files”) of a pharmacy located in the same community as one of PharmaCorp’s existing PharmaChoice-bannered pharmacies in Western Canada (the “Acquisition”). The purchase...

Continue reading

Pacific Health Care Organization, Inc. Reports its First Quarter 2026 Financial Results

Irvine, California, May 01, 2026 (GLOBE NEWSWIRE) — Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q announcing its financial results for the quarter ended March 31, 2026. Results The Company reported total revenues of $1,497,704 for the quarter ended March 31, 2026, compared to $1,818,814 for the quarter ended March 31, 2025. The Company reported income from operations of $172,684 for the quarter ended March 31, 2026, compared to income from operations of $314,419 for the quarter ended March 31, 2025. The Company realized net income of $193,669 or $0.02 per weighted average share outstanding, basic and diluted, for the quarter ended March 31, 2026, compared to net income of $292,663 or $0.02 per weighted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.